AU2019900626A0 - Concealment of hypomineralised lesions - Google Patents

Concealment of hypomineralised lesions

Info

Publication number
AU2019900626A0
AU2019900626A0 AU2019900626A AU2019900626A AU2019900626A0 AU 2019900626 A0 AU2019900626 A0 AU 2019900626A0 AU 2019900626 A AU2019900626 A AU 2019900626A AU 2019900626 A AU2019900626 A AU 2019900626A AU 2019900626 A0 AU2019900626 A0 AU 2019900626A0
Authority
AU
Australia
Prior art keywords
hypomineralised
concealment
lesions
hypomineralised lesions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2019900626A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Original Assignee
University of Melbourne
Filing date
Publication date
Application filed by University of Melbourne filed Critical University of Melbourne
Publication of AU2019900626A0 publication Critical patent/AU2019900626A0/en
Withdrawn legal-status Critical Current

Links

AU2019900626A 2019-02-27 Concealment of hypomineralised lesions Withdrawn AU2019900626A0 (en)

Publications (1)

Publication Number Publication Date
AU2019900626A0 true AU2019900626A0 (en) 2019-03-14

Family

ID=

Similar Documents

Publication Publication Date Title
EP3937881A4 (en) Concealment of hypomineralised lesions
EP3801503A4 (en) Inhibitors of sarm1
EP3982949A4 (en) Inhibitors of sarm1
EP3980011A4 (en) Inhibitors of sarm1
EP3966209A4 (en) Jak inhibitors
EP4083034A4 (en) Compound having khk inhibitory effect
EP4070183A4 (en) Behavior-based comparison of software
EP3752001A4 (en) Derivatives of sobetirome
EP4028085A4 (en) Intranasal administration of esketamine
EP3801500A4 (en) Inhibitors of sarm1
EP4049159A4 (en) Ransomware prevention
EP3972598A4 (en) Novel uses of crenolanib
EP3893882A4 (en) Cxcr7 inhibitors for the treatment of cancer
EP3814324A4 (en) Cathepsin c inhibitors
EP3801525A4 (en) Inhibitors of prolyl-trna-synthetase
EP4062820A4 (en) Endoscope
AU2019900833A0 (en) Concealment of hypomineralised lesions
AU2019900626A0 (en) Concealment of hypomineralised lesions
EP4024114A4 (en) Endoscope
EP4037741A4 (en) Inhaler
EP4021858A4 (en) Treatment of azoles
EP4009967A4 (en) Jak inhibitors
EP3991538A4 (en) Combine
EP3884944A4 (en) Application of chidamide
EP3934632A4 (en) Esketamine for the treatment of depression